Want to see IN:KILITCH full AI Analyst Report?
Kilitch Drugs (India) Limited (KILITCH) Financial Statements
Kilitch Drugs (India) Limited Financial Overview
Kilitch Drugs (India) Limited's market cap is currently $7.03B. The company's EPS TTM is $8.82; its P/E ratio is 22.81; and it has a dividend yield of 0.40%. Kilitch Drugs (India) Limited is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
| Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 2.35B | $ 1.98B | $ 1.54B | $ 1.40B | $ 1.14B |
| Gross Profit | $ 914.13M | $ 937.39M | $ 731.38M | $ 624.64M | $ 337.44M |
| Operating Income | $ 329.77M | $ 283.55M | $ 211.11M | $ 148.60M | $ 89.85M |
| EBITDA | $ 478.38M | $ 426.26M | $ 287.43M | $ 206.50M | $ 134.13M |
| Net Income | $ 301.66M | $ 267.01M | $ 146.01M | $ 104.48M | $ 73.67M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 687.39M | $ 593.98M | $ 690.19M | $ 591.77M | $ 572.43M |
| Total Assets | $ 4.58B | $ 3.13B | $ 2.40B | $ 2.20B | $ 2.10B |
| Total Debt | $ 887.09M | $ 494.24M | $ 316.46M | $ 221.94M | $ 204.32M |
| Net Debt | $ 719.33M | $ 396.24M | $ 127.36M | $ 23.48M | $ 104.22M |
| Total Liabilities | $ 1.81B | $ 1.12B | $ 643.88M | $ 689.41M | $ 695.55M |
| Stockholders' Equity | $ 2.80B | $ 2.02B | $ 1.76B | $ 1.52B | $ 1.39B |
| Cash Flow | |||||
| Free Cash Flow | $ -805.64M | $ -293.31M | $ -65.97M | $ -12.26M | $ -24.19M |
| Operating Cash Flow | $ 189.43M | $ 175.42M | $ -1.46M | $ 25.86M | $ 57.83M |
| Investing Cash Flow | $ -1.01B | $ -399.47M | $ -95.45M | $ 79.15M | $ -152.50M |
| Financing Cash Flow | $ 880.13M | $ 132.43M | $ 88.07M | $ -7.16M | $ 70.28M |
Currency in INR